These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2287792)

  • 21. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
    Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
    Holliday SM; Faulds D; Sorkin EM
    Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.
    Martin BG; Ratner PH; Hampel FC; Andrews CP; Toler T; Wu W; Faris MA; Philpot EE
    Allergy Asthma Proc; 2007; 28(2):216-25. PubMed ID: 17479608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
    Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis.
    Scadding GK; Lund VJ; Jacques LA; Richards DH
    Clin Exp Allergy; 1995 Aug; 25(8):737-43. PubMed ID: 7584685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
    Grahnén A; Eckernäs SA; Brundin RM; Ling-Andersson A
    Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis.
    Wiseman LR; Benfield P
    Drugs; 1997 May; 53(5):885-907. PubMed ID: 9129872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers.
    Mackie AE; Bye A
    Clin Pharmacokinet; 2000; 39 Suppl 1():47-54. PubMed ID: 11140433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
    Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR
    J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
    Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed.
    Dolovich J; O'Connor M; Stepner N; Smith A; Sharma RK
    Ann Allergy; 1994 May; 72(5):435-40. PubMed ID: 8179230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of orally administered micronised fluticasone propionate.
    Falcoz C; Oliver R; McDowall JE; Ventresca P; Bye A; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():9-15. PubMed ID: 11140434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological availability of inhaled fluticasone propionate in horses.
    Laan TT; Westermann CM; Dijkstra AV; van Nieuwstadt RA; Fink-Gremmels J
    Vet Rec; 2004 Sep; 155(12):361-4. PubMed ID: 15493604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily.
    Ratner PH; Paull BR; Findlay SR; Hampel F; Martin B; Kral KM; Rogenes PR
    J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):285-91. PubMed ID: 1527313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic bioavailability of fluticasone proprionate.
    Lipworth BJ
    Br J Clin Pharmacol; 2001 Oct; 52(4):457-60. PubMed ID: 11678793
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
    Wales D; Makker H; Kane J; McDowell P; O'Driscoll BR
    Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
    Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
    Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.